...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of the advanced practitioner in oncology >Venous Thromboembolism in the Cancer Population: Pathology, Risk, and Prevention
【24h】

Venous Thromboembolism in the Cancer Population: Pathology, Risk, and Prevention

机译：癌症人群的静脉血栓栓塞症：病理，风险和预防。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Patients with cancer have an increased risk of developing venous thromboembolism (VTE) and the incidence of these events has been increasing over the past decade. Venous thromboembolic events include both deep venous thrombosis and pulmonary embolism. These events contribute to higher morbidity and mortality rates. Understanding the complex pathogenesis of and risk factors for cancer-associated VTE will help guide advanced practitioners to improve outcomes with prophylaxis. The American Society of Clinical Oncology, the National Comprehensive Cancer Network, and the European Society of Medical Oncology have utilized this information and developed evidence-based guidelines for prophylactic management for those who are at highest risk of developing cancer-associated VTE. This review will discuss the impact of cancer-associated VTE as well as its underlying pathogenesis, risk factors, and current recommendations for prophylaxis.
机译：癌症患者罹患静脉血栓栓塞症（VTE）的风险增加，并且在过去十年中，这些事件的发生率一直在增加。静脉血栓栓塞事件包括深部静脉血栓形成和肺栓塞。这些事件导致较高的发病率和死亡率。了解与癌症相关的VTE的复杂发病机理和危险因素将有助于指导高级从业者改善预防效果。美国临床肿瘤学会，美国国家综合癌症网络和欧洲医学肿瘤学会已利用这些信息，为那些罹患与癌症相关的VTE风险最高的人群的预防性治疗制定了循证指南。这篇综述将讨论与癌症有关的VTE的影响及其潜在的发病机理，危险因素以及当前的预防建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号